Literature DB >> 6426035

Urinary 99m-Tc-diphosphonate excretion as a simple method to quantify bone metabolism.

L Hyldstrup, N Mogensen, G F Jensen, P McNair, I Transbøl.   

Abstract

Twenty-four-hour whole-body retention (WBR) of 99m-Tc-methylene-diphosphonate (an index of bone turnover) was determined by whole-body counting (WBRs) and complementarily by urine counting (WBRu) in nineteen subjects with normal to highly increased bone turnover. WBRs and WBRu correlated well (r = 0.94, P less than 0.001), and gave almost the same results. Both WBRs correlated equally well with serum alkaline phosphatase and urine hydroxyproline/creatinine (r = 0.82-0.93). Coefficient of variation in WBRu was 7.0%, determined by duplicate measurements in sixteen normals. The injected dose of diphosphonate did not influence WBRu. However, since almost 50% of the diphosphonate excreted in urine appeared during the first few hours after the i.v. injection, the method of WBRu requires careful urine collection. Thus, the simple WBRu determination provides the same information on bone metabolism as does the more cumbersome and expensive WBRs technique.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6426035     DOI: 10.3109/00365518409161390

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  10 in total

1.  On the pharmacological evaluation of bisphosphonates in humans.

Authors:  Serge Cremers; Frank Hal Ebetino; Roger Phipps
Journal:  Bone       Date:  2020-06-27       Impact factor: 4.398

2.  Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.

Authors:  L Hyldstrup; P McNair; P Ring; O Henriksen
Journal:  Eur J Nucl Med       Date:  1987

3.  99mTc-MDP retention in osteoporosis: relationship to other indices of bone cell activity and response to calcium and vitamin D therapy.

Authors:  M W Davie; J M Britton; M Haddaway; I W McCall
Journal:  Eur J Nucl Med       Date:  1987

4.  Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.

Authors:  C Gennari; D Agnusdei; A Camporeale
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

5.  Whole body retention of 99mTc-diphosphonate. Relation to biochemical indices of bone turnover and to total body calcium.

Authors:  K Thomsen; J Johansen; L Nilas; C Christiansen
Journal:  Eur J Nucl Med       Date:  1987

6.  Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors:  R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

7.  Determination of bone turnover by urinary excretion of 99mTc-MDP.

Authors:  K Thomsen; L Nilas; T Mogensen; C Christiansen
Journal:  Eur J Nucl Med       Date:  1986

8.  Pharmacokinetic evaluation of pamidronate after oral administration: a study on dose proportionality, absolute bioavailability, and effect of repeated administration.

Authors:  L Hyldstrup; G Flesch; S A Hauffe
Journal:  Calcif Tissue Int       Date:  1993-11       Impact factor: 4.333

9.  Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.

Authors:  S Molloi; R Mazess; H Bendsen; M Wilson
Journal:  Calcif Tissue Int       Date:  1989-05       Impact factor: 4.333

Review 10.  Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis.

Authors:  Serge C L M Cremers; Goonaseelan Pillai; Socrates E Papapoulos
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.